WSK-IM02

BIOLOGICAL2 trials

Sponsors

WestVac Biopharma Co., Ltd.

Conditions

Advanced Solid TumorsMalignant AscitesMalignant Pleural EffusionsPlatinum-resistant Recurrent Ovarian Cancer (PROC)

Phase 1

A Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer.

Not yet recruitingNCT07462468

WestVac Biopharma Co., Ltd.Platinum-resistant Recurrent Ovarian Cancer (PROC)

Start: 2026-03-10End: 2027-09-30Target: 36Updated: 2026-03-13

WSK-IM02 in Advanced Solid Tumors With Malignant Effusions (Phase I)

Not yet recruitingNCT07615894

WestVac Biopharma Co., Ltd.Advanced Solid Tumors, Malignant Ascites, Malignant Pleural Effusions

Start: 2026-06-01End: 2029-06-30Target: 9Updated: 2026-05-29